Physician profile
Michael Coleman
NPI 1447258694
$2,166.25
in general payments reported to CMS, 2019-2025
21 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $522 · 2020: $94.56 · 2021: $456 · 2022: $296 · 2023: $392 · 2024: $261 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $797.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $874.51 | 2019-2025 | Clareon, Hydrus Microstent, Argos |
| Abbvie INC. | $153.29 | 2022-2024 | Alphagan P, Lumigan |
| Aerie Pharmaceuticals, INC. | $147.34 | 2019-2021 | |
| Glaukos Corporation | $115.31 | 2019-2024 | Photrexa, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Sight Sciences, INC. | $104.57 | 2019-2022 | |
| Allergan, INC. | $99.56 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $90.34 | 2019-2023 | Cequa |
| Bausch & Lomb Americas INC. | $87.65 | 2022-2025 | Miebo, Lotemax Sm |
| Rxsight INC | $81.01 | 2023-2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Thea Pharma INC. | $57.04 | 2024-2025 | Iyuzeh |
| Johnson & Johnson Surgical Vision, INC. | $54.13 | 2021-2022 | |
| Harrow Eye, LLC | $49.78 | 2023-2024 | Iheezo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $47.51 | 2019 | |
| Ocular Therapeutix, INC. | $45.78 | 2023 | Dextenza |
| Novartis Pharmaceuticals Corporation | $35.47 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $29.46 | 2021-2023 | |
| Shire North American Group INC | $23.40 | 2019 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $23.09 | 2024 | |
| Carl Zeiss Meditec, INC. | $17.93 | 2021 | |
| Biotissue Holdings INC. | $14.58 | 2022 | |
| Rayner Intraocular Lenses Limited | $14.50 | 2023 | Omidria, Rayone Spheric, Rayone Emv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Coleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.